IXJ iShares Global Healthcare ETF Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
06:58
Jul 01
Lorraine Tan Morningstar Director of Asia Equity Research Bloomberg Markets
Asian healthcare ripe for re-rating.
Healthcare in Asia underperformed last quarter and is ripe for re-rating upward, with quality names like Chinese biotech offering solid drug portfolios and decent growth rates.
IXJ 1ST
MED
07:21
Jun 02
Vikas Pershad Portfolio Manager, M&G Investments Bloomberg Markets
Healthcare mispriced, buy Asian healthcare.
Healthcare is mispriced across Asia, including Indian services, Japanese pharma, with high cash flow and dividends, while AI stocks are overvalued.
IXJ 1ST
MED

About IXJ Analyst Coverage

Buzzberg tracks IXJ (iShares Global Healthcare ETF) across 1 sources. 2 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked. Latest voices: Lorraine Tan, Vikas Pershad.